Biotech Values

[DewDiligence]

SHPG acquires (private) Meritage Pharma for $70M cash plus contingencies:

http://finance.yahoo.com/news/shire-acquires-meritage-pharma-120000158.html

Shire plc and Meritage Pharma, Inc. announced today that Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones. With the acquisition, Shire has acquired the global rights to-and undertaken the further development of-Meritage's Phase 3-ready compound, Oral Budesonide Suspension (OBS), for the treatment of adolescents and adults with eosinophilic esophagitis (EoE), a rare, chronic inflammatory gastrointestinal (GI) disease.

…Shire obtained the rights to acquire Meritage in connection with its acquisition of ViroPharma in 2014.